Regentatlantic Capital LLC lessened its position in shares of Aetna Inc (NYSE:AET) by 8.9% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 86,901 shares of the company’s stock after selling 8,444 shares during the period. Aetna accounts for 1.3% of Regentatlantic Capital LLC’s investment portfolio, making the stock its 11th largest position. Regentatlantic Capital LLC’s holdings in Aetna were worth $15,676,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. GSA Capital Partners LLP purchased a new stake in Aetna during the 2nd quarter worth about $350,000. D.A. Davidson & CO. lifted its holdings in Aetna by 3.2% during the 2nd quarter. D.A. Davidson & CO. now owns 7,341 shares of the company’s stock worth $1,114,000 after purchasing an additional 225 shares in the last quarter. FIL Ltd purchased a new stake in Aetna during the 2nd quarter worth about $8,646,000. Advisor Group Inc. lifted its holdings in Aetna by 23.2% during the 2nd quarter. Advisor Group Inc. now owns 16,292 shares of the company’s stock worth $2,453,000 after purchasing an additional 3,073 shares in the last quarter. Finally, Veritable L.P. lifted its holdings in Aetna by 0.9% during the 2nd quarter. Veritable L.P. now owns 10,763 shares of the company’s stock worth $1,634,000 after purchasing an additional 94 shares in the last quarter. 87.88% of the stock is currently owned by hedge funds and other institutional investors.

Shares of Aetna Inc (NYSE:AET) traded up $1.54 during trading on Tuesday, hitting $189.34. The stock had a trading volume of 2,576,400 shares, compared to its average volume of 2,897,514. The company has a debt-to-equity ratio of 0.52, a current ratio of 0.53 and a quick ratio of 0.53. The company has a market cap of $61,690.00, a price-to-earnings ratio of 35.00, a PEG ratio of 1.59 and a beta of 0.61. Aetna Inc has a 12-month low of $116.04 and a 12-month high of $192.37.

Aetna (NYSE:AET) last announced its quarterly earnings data on Tuesday, October 31st. The company reported $2.45 EPS for the quarter, beating the consensus estimate of $2.06 by $0.39. The firm had revenue of $14.99 billion for the quarter, compared to analyst estimates of $15.12 billion. Aetna had a return on equity of 21.84% and a net margin of 2.93%. The company’s revenue was down 5.0% on a year-over-year basis. During the same period in the prior year, the company earned $2.07 EPS. analysts expect that Aetna Inc will post 9.78 EPS for the current year.

The company also recently disclosed a quarterly dividend, which will be paid on Friday, January 26th. Stockholders of record on Thursday, January 11th will be given a dividend of $0.50 per share. The ex-dividend date of this dividend is Wednesday, January 10th. This represents a $2.00 annualized dividend and a dividend yield of 1.06%. Aetna’s dividend payout ratio (DPR) is presently 36.97%.

A number of brokerages recently issued reports on AET. Deutsche Bank raised Aetna from a “hold” rating to a “buy” rating and increased their price objective for the stock from $195.00 to $212.00 in a report on Monday. Zacks Investment Research cut Aetna from a “buy” rating to a “hold” rating in a report on Tuesday, October 3rd. Cantor Fitzgerald reissued a “neutral” rating and set a $175.00 price objective on shares of Aetna in a report on Monday, October 23rd. Citigroup increased their price objective on Aetna from $183.00 to $197.00 and gave the stock a “buy” rating in a report on Thursday, November 2nd. Finally, Piper Jaffray Companies raised Aetna from a “neutral” rating to an “overweight” rating and set a $136.00 price objective on the stock in a report on Wednesday, January 3rd. Eleven equities research analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company’s stock. The stock presently has a consensus rating of “Buy” and an average price target of $175.09.

TRADEMARK VIOLATION NOTICE: “Regentatlantic Capital LLC Sells 8,444 Shares of Aetna Inc (AET)” was originally posted by Daily Political and is the property of of Daily Political. If you are reading this report on another website, it was copied illegally and republished in violation of U.S. & international copyright & trademark legislation. The legal version of this report can be read at https://www.dailypolitical.com/2018/01/23/regentatlantic-capital-llc-sells-8444-shares-of-aetna-inc-aet.html.

About Aetna

Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services.

Want to see what other hedge funds are holding AET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aetna Inc (NYSE:AET).

Institutional Ownership by Quarter for Aetna (NYSE:AET)

Receive News & Ratings for Aetna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna and related companies with MarketBeat.com's FREE daily email newsletter.